Chemo-Re-Irradiation and Salvage Surgery for Locally Recurrent Rectal Cancer

Paul B Romesser^{1

2}, Christopher H Crane^{3

4}

Affiliations

¹ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. romessep@mskcc.org.
² Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. romessep@mskcc.org.
³ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Cranec1@mskcc.org.
⁴ Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Cranec1@mskcc.org.

Editorial

Paul B Romesser et al. Ann Surg Oncol. 2021 Sep.

. 2021 Sep;28(9):4769-4771.

doi: 10.1245/s10434-021-10198-5. Epub 2021 May 24.

Paul B Romesser^{1

2}, Christopher H Crane^{3

4}

¹ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. romessep@mskcc.org.
² Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. romessep@mskcc.org.
³ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Cranec1@mskcc.org.
⁴ Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Cranec1@mskcc.org.

No abstract available

Comment on

Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
Dijkstra EA, Mul VEM, Hemmer PHJ, Havenga K, Hospers GAP, Muijs CT, van Etten B. Dijkstra EA, et al. Ann Surg Oncol. 2021 Sep;28(9):5194-5204. doi: 10.1245/s10434-021-10070-6. Epub 2021 May 22. Ann Surg Oncol. 2021. PMID: 34023946 Free PMC article.

1. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–40. - DOI
1. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol. 2004;72(1):15–24. - DOI
1. Ngan SY, Burmeister B, Fisher RJ, et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: trans-Tasman radiation oncology group trial 01.04. J Clin Oncol. 2012;30(31):3827–33. - DOI
1. Erlandsson J, Holm T, Pettersson D, et al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol. 2017;18(3):336–46. - DOI
1. Terezakis S, Morikawa L, Wu A, et al. Long-term survival after high-dose-rate brachytherapy for locally advanced or recurrent colorectal adenocarcinoma. Ann Surg Oncol. 2015;22(7):2168–78. - DOI